Clinical development of an anti-GPC-1 antibody for the treatment of cancer
Sign Up to like & getrecommendations! Published in 2022 at "Expert Opinion on Biological Therapy"
DOI: 10.1080/14712598.2022.2033204
Abstract: ABSTRACT Introduction Glypican-1 (GPC-1) is a heparan sulfate proteoglycan (HSPG) overexpressed in multiple cancers. Multiple studies indicate the prominence of this cancer biomarker with significant diagnostic and therapeutic potential. Recent advances in monoclonal antibody (mAb)-based… read more here.
Keywords: anti gpc; gpc; gpc antibody; clinical development ... See more keywords